Cargando…
TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652458/ http://dx.doi.org/10.1186/2051-1426-3-S2-P441 |
| _version_ | 1782401758218158080 |
|---|---|
| author | Nemunaitis, John Papai, Zsolt Léna, Hervé Losonczy, Gyorgy Forget, Frederic Chouaid, Christos Szczesna, Alexandra Gervais, Radj Ottensmeier, Christian H Beck, Joseph Kazarnowicz, Andrzej Westeel, Virginie Debieuvre, Didier Madroszyk, Anne Felip, Enriqueta Limacher, Jean Marc Quoix, Elisabeth |
| author_facet | Nemunaitis, John Papai, Zsolt Léna, Hervé Losonczy, Gyorgy Forget, Frederic Chouaid, Christos Szczesna, Alexandra Gervais, Radj Ottensmeier, Christian H Beck, Joseph Kazarnowicz, Andrzej Westeel, Virginie Debieuvre, Didier Madroszyk, Anne Felip, Enriqueta Limacher, Jean Marc Quoix, Elisabeth |
| author_sort | Nemunaitis, John |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4652458 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46524582015-11-25 TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial Nemunaitis, John Papai, Zsolt Léna, Hervé Losonczy, Gyorgy Forget, Frederic Chouaid, Christos Szczesna, Alexandra Gervais, Radj Ottensmeier, Christian H Beck, Joseph Kazarnowicz, Andrzej Westeel, Virginie Debieuvre, Didier Madroszyk, Anne Felip, Enriqueta Limacher, Jean Marc Quoix, Elisabeth J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4652458/ http://dx.doi.org/10.1186/2051-1426-3-S2-P441 Text en Copyright © 2015 Nemunaitis et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Nemunaitis, John Papai, Zsolt Léna, Hervé Losonczy, Gyorgy Forget, Frederic Chouaid, Christos Szczesna, Alexandra Gervais, Radj Ottensmeier, Christian H Beck, Joseph Kazarnowicz, Andrzej Westeel, Virginie Debieuvre, Didier Madroszyk, Anne Felip, Enriqueta Limacher, Jean Marc Quoix, Elisabeth TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial |
| title | TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial |
| title_full | TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial |
| title_fullStr | TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial |
| title_full_unstemmed | TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial |
| title_short | TG4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (NSCLC): Phase IIb results of the TIME trial |
| title_sort | tg4010 immunotherapy plus chemotherapy as first-line treatment of advanced non small cell lung cancer (nsclc): phase iib results of the time trial |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652458/ http://dx.doi.org/10.1186/2051-1426-3-S2-P441 |
| work_keys_str_mv | AT nemunaitisjohn tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT papaizsolt tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT lenaherve tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT losonczygyorgy tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT forgetfrederic tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT chouaidchristos tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT szczesnaalexandra tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT gervaisradj tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT ottensmeierchristianh tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT beckjoseph tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT kazarnowiczandrzej tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT westeelvirginie tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT debieuvredidier tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT madroszykanne tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT felipenriqueta tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT limacherjeanmarc tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial AT quoixelisabeth tg4010immunotherapypluschemotherapyasfirstlinetreatmentofadvancednonsmallcelllungcancernsclcphaseiibresultsofthetimetrial |